DiGeorge Syndrome (DGS) Patient Derived iPSCs
Closed Solicitation Posted
- Solicitation number
- 75N92024Q1031
- Agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- Q301 Reference Laboratory Testing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute is seeking to procure DiGeorge Syndrome (DGS) Patient Derived induced pluripotent stem cells (iPSCs) through this Solicitation. The contractor shall provide 3 patient-derived iPSC lines with isogenic controls, which will be used to generate neural crest cells and derivatives to study the effects of the DGS deletion mutation. The contractor is required to follow a specific workflow for iPSC generation, quality control, and delivery of 6 vials per line within 6-9 months of receiving the starting materials. The contract will be awarded to the responsible offeror whose quote conforming to the solicitation is most advantageous to the government, considering price and other factors.
This opportunity is not set-aside for any particular business type. The solicitation does not name any potential incumbents or current contractors. The solicitation does not specify an award value or budget range. The key numerical details are the requirement for 3 patient-derived iPSC lines with isogenic controls, and the delivery of 6 vials per line within 6-9 months. The place of performance is not specified.
Notice text
DiGeorge Syndrome (DGS) Patient Derived induced pluripotent stem cells (iPSCs)
Files
| File | Type | Posted |
|---|---|---|
| Sol_75N92024Q1031.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity